Phase 1–2 Clinical Trial of Trifluoperazine for Glioblastoma: Pharmacokinetics and safety via intracranial vs. oral Delivery

Bardy, Cedric (Chief Investigator (Project Lead))
Gan, Hui (Chief Investigator)
Kichenadasse, Ganessan (Chief Investigator)
Poonnoose, Santosh (Chief Investigator)
Koh, Eng-Siew (Chief Investigator)
Sim, Hao Wen (Chief Investigator)
De Silva, Manam Inushi (Chief Investigator)
Bright, Fiona (Chief Investigator)

Austin Hospital
Liverpool Cancer Therapy Centre
University of New South Wales
South Australian Health and Medical Research Institute

Status	Active
Effective start/end date	26/11/25 → 26/11/28